Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in non-diabetic chronic kidney disease
CTR20212637Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finerenone in chronic kidney disease (CKD), sponsored by Bayer. Started Jan 2022; status: completed.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20212637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212637.